{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T17:44:32Z","timestamp":1792172672383,"version":"4.4.0"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s12974-018-1067-y","type":"journal-article","created":{"date-parts":[[2018,2,13]],"date-time":"2018-02-13T00:23:26Z","timestamp":1518481406000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":77,"title":["A clinical approach to new-onset psychosis associated with immune dysregulation: the concept of autoimmune psychosis"],"prefix":"10.1186","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4701-1503","authenticated-orcid":false,"given":"Souhel","family":"Najjar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johann","family":"Steiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Najjar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl","family":"Bechter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,2,13]]},"reference":[{"key":"1067_CR1","first-page":"43","volume":"10","author":"S Najjar","year":"2013","unstructured":"Najjar S, Pearlman DM, Alper K, Najjar A, Devinsky O. Neuroinflammation and psychiatric illness. J Neuroinflammation. 2013;10:43.","journal-title":"J Neuroinflammation"},{"key":"1067_CR2","doi-asserted-by":"publisher","first-page":"83","DOI":"10.3389\/fpsyt.2017.00083","volume":"8","author":"S Najjar","year":"2017","unstructured":"Najjar S, Pahlajani S, De Sanctis V, Stern JNH, Najjar A, Chong D. Neurovascular unit dysfunction and blood-brain barrier hyperpermeability contribute to schizophrenia neurobiology: a theoretical integration of clinical and experimental evidence. Front Psychiatry. 2017;8:83.","journal-title":"Front Psychiatry"},{"key":"1067_CR3","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s00401-006-0090-8","volume":"112","author":"J Steiner","year":"2006","unstructured":"Steiner J, Mawrin C, Ziegeler A, et al. Distribution of HLA-DR-positive microglia in schizophrenia reflects impaired cerebral lateralization. Acta Neuropathol. 2006;112:305\u201316.","journal-title":"Acta Neuropathol"},{"key":"1067_CR4","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jpsychires.2006.10.013","volume":"42","author":"J Steiner","year":"2008","unstructured":"Steiner J, Bielau H, Brisch R, et al. Immunological aspects in the neurobiology of suicide: elevated microglial density in schizophrenia and depression is associated with suicide. J Psychiatr Res. 2008;42:151\u20137.","journal-title":"J Psychiatr Res"},{"key":"1067_CR5","doi-asserted-by":"publisher","first-page":"e1075","DOI":"10.1038\/tp.2017.4","volume":"7","author":"CF Van Kesteren","year":"2017","unstructured":"Van Kesteren CF, Gremmels H, de Witte LD, et al. Immune involvement in the pathogenesis of schizophrenia: a meta-analysis on postmortem brain studies. Transl Psychiatry. 2017;7:e1075.","journal-title":"Transl Psychiatry"},{"key":"1067_CR6","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.bbi.2008.08.007","volume":"23","author":"S Chittiprol","year":"2009","unstructured":"Chittiprol S, Venkatasubramanian G, Neelakantachar N, Allha N, Shetty KT, Gangadhar BN. Beta2-microglobulin abnormalities in antipsychotic-na\u00efve schizophrenia: evidence for immune pathogenesis. Brain Behav Immun. 2009;23:189\u201392.","journal-title":"Brain Behav Immun"},{"key":"1067_CR7","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1016\/j.intimp.2009.07.002","volume":"9","author":"S Chittiprol","year":"2009","unstructured":"Chittiprol S, Venkatasubramanian G, Neelakantachar N, Reddy NA, Shetty KT, Gangadhar BN. Longitudinal study of beta2-microglobulin abnormalities in schizophrenia. Int Immunopharmacol. 2009;9:1215\u20137.","journal-title":"Int Immunopharmacol"},{"key":"1067_CR8","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.jpsychires.2009.08.008","volume":"44","author":"K Bechter","year":"2010","unstructured":"Bechter K, Reiber H, Herzog S, Fuchs D, Tumani H, Maxeiner HG. Cerebrospinal fluid analysis in affective and schizophrenic spectrum disorders: identification of subgroups with immune responses and blood-CSF barrier dysfunction. Psychiatry Res. 2010;44:321\u201330.","journal-title":"Psychiatry Res"},{"key":"1067_CR9","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.cyto.2014.05.008","volume":"69","author":"HG Maxeiner","year":"2014","unstructured":"Maxeiner HG, Marion Schneider E, Kurfiss ST, Brettschneider J, Tumani H, Bechter K. Cerebrospinal fluid and serum cytokine profiling to detect immune control of infectious and inflammatory neurological and psychiatric diseases. Cytokine. 2014;69:62\u20137.","journal-title":"Cytokine"},{"key":"1067_CR10","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.psychres.2016.09.029","volume":"247","author":"S Chen","year":"2017","unstructured":"Chen S, Tian L, Chen N, et al. Cognitive dysfunction correlates with elevated serum S100B concentration in drug-free acutely relapsed patients with schizophrenia. Psychiatry Res. 2017;247:6\u201311.","journal-title":"Psychiatry Res"},{"key":"1067_CR11","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1111\/j.1749-6632.2012.06638.x","volume":"1262","author":"ME Benros","year":"2012","unstructured":"Benros ME, Mortensen PB, Eaton WW. Autoimmune diseases and infections as risk factors for schizophrenia. Ann N Y Acad Sci. 2012;1262:56\u201366.","journal-title":"Ann N Y Acad Sci"},{"key":"1067_CR12","doi-asserted-by":"publisher","first-page":"e1192","DOI":"10.1038\/tp.2017.134","volume":"7","author":"LJ Glass","year":"2017","unstructured":"Glass LJ, Sinclair D, Boerrigter D, et al. Brain antibodies in the cortex and blood of people with schizophrenia and controls. Transl Psychiatry. 2017;7:e1192.","journal-title":"Transl Psychiatry"},{"key":"1067_CR13","doi-asserted-by":"publisher","unstructured":"Mohagheghi M, Alikhani MY, Taheri M, Eftekharian MM. Determining the IgM and IgG antibodies titer against HSV1, HSV2 and CMV in the serum of schizophrenia patients. Hum Antibodies. 2017. https:\/\/doi.org\/10.3233\/HAB-170325 .","DOI":"10.3233\/HAB-170325"},{"key":"1067_CR14","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/S0165-5728(03)00252-2","volume":"141","author":"S Tanaka","year":"2003","unstructured":"Tanaka S, Matsunaga H, Kimura M, et al. Autoantibodies against four kinds of neurotransmitter receptors in psychiatric disorders. J Neuroimmunol. 2003;141:155\u201364.","journal-title":"J Neuroimmunol"},{"key":"1067_CR15","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1002\/glia.10312","volume":"45","author":"T Borda","year":"2004","unstructured":"Borda T, Gomez R, Berr\u00eda MI, Sterin-Borda L. Antibodies against astrocyte M1 and M2 muscarinic cholinoceptor from schizophrenic patients\u2019 sera. Glia. 2004;45:144\u201354.","journal-title":"Glia"},{"key":"1067_CR16","doi-asserted-by":"publisher","first-page":"150064","DOI":"10.1098\/rsob.150064","volume":"5","author":"EA Ermakov","year":"2015","unstructured":"Ermakov EA, Smirnova LP, Parkhomenko TA, et al. DNA-hydrolysing activity of IgG antibodies from the sera of patients with schizophrenia. Open Biol. 2015;5:150064.","journal-title":"Open Biol"},{"key":"1067_CR17","doi-asserted-by":"publisher","first-page":"54","DOI":"10.3389\/fpsyt.2017.00054","volume":"8","author":"P Ellul","year":"2017","unstructured":"Ellul P, Groc L, Tamouza R, Leboyer M. The clinical challenge of autoimmune psychosis: learning from anti-NMDA receptor autoantibodies. Front Psychiatry. 2017;8:54.","journal-title":"Front Psychiatry"},{"key":"1067_CR18","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1176\/appi.neuropsych.23.1.90","volume":"23","author":"MS Kayser","year":"2011","unstructured":"Kayser MS, Dalmau J. The emerging link between autoimmune disorders and neuropsychiatric disease. J Neuropsychiatry Clin Neurosci. 2011;23:90\u20137.","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"1067_CR19","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1001\/2013.jamapsychiatry.86","volume":"70","author":"J Steiner","year":"2013","unstructured":"Steiner J, Walter M, Glanz W, et al. Increased prevalence of diverse N-methyl-D-aspartate glutamate receptor antibodies in patients with an initial diagnosis of schizophrenia: specific relevance of IgG NR1a antibodies for distinction from N-methyl-D-aspartate glutamate receptor encephalitis. JAMA Psychiatry. 2013;70:271\u20138.","journal-title":"JAMA Psychiatry"},{"key":"1067_CR20","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1001\/jamapsychiatry.2014.469","volume":"71","author":"J Steiner","year":"2014","unstructured":"Steiner J, Teegen B, Schiltz K, Bernstein HG, Stoecker W, Bogerts B. Prevalence of N-methyl-D-aspartate receptor autoantibodies in the peripheral blood: healthy control samples revisited. JAMA Psychiatry. 2014;71:838\u20139.","journal-title":"JAMA Psychiatry"},{"key":"1067_CR21","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/S2215-0366(16)30375-3","volume":"4","author":"BR Lennox","year":"2017","unstructured":"Lennox BR, Palmer-Cooper EC, Pollak T, et al. Prevalence and clinical characteristics of serum neuronal cell surface antibodies in first-episode psychosis: a case-control study. Lancet Psychiatry. 2017;4:42\u20138.","journal-title":"Lancet Psychiatry"},{"key":"1067_CR22","doi-asserted-by":"publisher","first-page":"2775","DOI":"10.2147\/NDT.S82380","volume":"12","author":"C Bost","year":"2016","unstructured":"Bost C, Pascual O, Honnorat J. Autoimmune encephalitis in psychiatric institutions: current perspectives. Neuropsychiatr Dis Treat. 2016;12:2775\u201387.","journal-title":"Neuropsychiatr Dis Treat"},{"key":"1067_CR23","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s12888-016-1157-2","volume":"17","author":"IS Haussleiter","year":"2017","unstructured":"Haussleiter IS, Wandinger KP, Juckel G. A case of GABAR antibodies in schizophrenia. BMC Psychiatry. 2017;17:9.","journal-title":"BMC Psychiatry"},{"key":"1067_CR24","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.schres.2014.05.001","volume":"157","author":"DM Pearlman","year":"2014","unstructured":"Pearlman DM, Najjar S. Meta-analysis of the association between N-methyl-d-aspartate receptor antibodies and schizophrenia, schizoaffective disorder, bipolar disorder, and major depressive disorder. Schizophr Res. 2014;157:249\u201358.","journal-title":"Schizophr Res"},{"key":"1067_CR25","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/j.biopsych.2017.06.015","volume":"82","author":"J J\u00e9z\u00e9quel","year":"2017","unstructured":"J\u00e9z\u00e9quel J, Rogemond V, Pollak T, et al. Cell- and single molecule-based methods to detect anti-N-methyl-D-aspartate receptor autoantibodies in patients with first-episode psychosis from the OPTiMiSE project. Biol Psychiatry. 2017;82:766\u201372.","journal-title":"Biol Psychiatry"},{"key":"1067_CR26","doi-asserted-by":"publisher","first-page":"e0187156","DOI":"10.1371\/journal.pone.0187156","volume":"12","author":"CC Lin","year":"2017","unstructured":"Lin CC, Hung YY, Tsai MC, Huang TL. Increased serum anti-N-methyl-D-aspartate receptor antibody immunofluorescence in psychiatric patients with past catatonia. PLoS One. 2017;12:e0187156.","journal-title":"PLoS One"},{"key":"1067_CR27","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1007\/s00415-010-5788-9","volume":"258","author":"MS Zandi","year":"2011","unstructured":"Zandi MS, Irani SR, Lang B, et al. Disease-relevant autoantibodies in first episode schizophrenia. J Neurol. 2011;258:686\u20138.","journal-title":"J Neurol"},{"key":"1067_CR28","doi-asserted-by":"publisher","first-page":"257184","DOI":"10.1155\/2013\/257184","volume":"2013","author":"K Pathmanandavel","year":"2013","unstructured":"Pathmanandavel K, Starling J, Dale RC, Brilot F. Autoantibodies and the immune hypothesis in psychotic brain diseases: challenges and perspectives. Clin Dev Immunol. 2013;2013:257184.","journal-title":"Clin Dev Immunol"},{"key":"1067_CR29","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1002\/ana.24189","volume":"76","author":"L Dahm","year":"2014","unstructured":"Dahm L, Ott C, Steiner J, et al. Seroprevalence of autoantibodies against brain antigens in health and disease. Ann Neurol. 2014;76:82\u201394.","journal-title":"Ann Neurol"},{"key":"1067_CR30","doi-asserted-by":"crossref","unstructured":"Gaughran F, Lally J, Beck K, et al. Brain-relevant antibodies in first-episode psychosis: a matched case-control study. Psychol Med. 2017:1\u20139.","DOI":"10.1017\/S0033291717002689"},{"key":"1067_CR31","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/wps.20001","volume":"12","author":"MS Keshavan","year":"2013","unstructured":"Keshavan MS, Kaneko Y. Secondary psychoses: an update. World Psychiatry. 2013;12:4\u201315.","journal-title":"World Psychiatry"},{"key":"1067_CR32","doi-asserted-by":"publisher","first-page":"90","DOI":"10.4103\/0253-7176.96170","volume":"34","author":"RB Nayak","year":"2012","unstructured":"Nayak RB, Bhogale GS, Patil NM, Chate SS. Psychosis in patients with systemic lupus erythematosus. Indian J Psychol Med. 2012;34:90\u20133.","journal-title":"Indian J Psychol Med"},{"key":"1067_CR33","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","volume":"15","author":"F Graus","year":"2016","unstructured":"Graus F, Titulaer MJ, Balu R, et al. A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol. 2016;15:391\u2013404.","journal-title":"Lancet Neurol"},{"key":"1067_CR34","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3389\/fpsyt.2017.00025","volume":"8","author":"J Herken","year":"2017","unstructured":"Herken J, Pr\u00fcss H. Red flags: clinical signs for identifying autoimmune encephalitis in psychiatric patients. Front Psychiatry. 2017;8:25. eCollection 2017","journal-title":"Front Psychiatry"},{"key":"1067_CR35","doi-asserted-by":"publisher","first-page":"175","DOI":"10.2174\/1389200024605082","volume":"3","author":"C Murr","year":"2002","unstructured":"Murr C, Widner B, Wirleitner B, Fuchs D. Neopterin as a marker for immune system activation. Curr Drug Metab. 2002;3:175\u201387.","journal-title":"Curr Drug Metab"},{"key":"1067_CR36","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.neuroscience.2015.05.037","volume":"309","author":"J Heine","year":"2015","unstructured":"Heine J, Pr\u00fcss H, Bartsch T, Ploner CJ, Paul F, Finke C. Imaging of autoimmune encephalitis\u2014relevance for clinical practice and hippocampal function. Neuroscience. 2015;309:68\u201383.","journal-title":"Neuroscience"},{"key":"1067_CR37","doi-asserted-by":"crossref","unstructured":"Morbelli S, Djekidel M, Hesse S, Pagani M, Barthel H. Role of (18)F-FDG-PET imaging in the diagnosis of autoimmune encephalitis. Lancet Neurol. 2016;15:1009\u201310.","DOI":"10.1016\/S1474-4422(16)30140-5"},{"key":"1067_CR38","doi-asserted-by":"publisher","unstructured":"Pollak TA, Moran N. Emergence of new-onset psychotic disorder following recovery from LGI1 antibody-associated limbic encephalitis. BMJ Case Rep. 2017. https:\/\/doi.org\/10.1136\/bcr-2016-218328 .","DOI":"10.1136\/bcr-2016-218328"},{"key":"1067_CR39","doi-asserted-by":"publisher","first-page":"476","DOI":"10.3389\/fnhum.2015.00476","volume":"9","author":"D Endres","year":"2015","unstructured":"Endres D, Perlov E, Baumgartner A, et al. Immunological findings in psychotic syndromes: a tertiary care hospital\u2019s CSF sample of 180 patients. Front Hum Neurosci. 2015;9:476.","journal-title":"Front Hum Neurosci"},{"key":"1067_CR40","doi-asserted-by":"publisher","unstructured":"Pathmanandavel K, Starling J, Dale RC, Brilot F. Autoantibodies and the immune hypothesis in psychotic brain diseases: challenges and perspectives. Clin Dev Immunol. 2013;257184. https:\/\/doi.org\/10.1155\/2013\/257184 .","DOI":"10.1155\/2013\/257184"},{"key":"1067_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3988\/jcn.2016.12.1.1","volume":"12","author":"E Lancaster","year":"2016","unstructured":"Lancaster E. The diagnosis and treatment of autoimmune encephalitis. J Clin Neurol. 2016;12:1\u201313.","journal-title":"J Clin Neurol"},{"key":"1067_CR42","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1002\/ana.21589","volume":"65","author":"M Lai","year":"2009","unstructured":"Lai M, Hughes EG, Peng X, et al. AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location. Ann Neurol. 2009;65:424\u201334.","journal-title":"Ann Neurol"},{"key":"1067_CR43","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.3174\/ajnr.A5086","volume":"38","author":"BP Kelley","year":"2017","unstructured":"Kelley BP, Patel SC, Marin HL, Corrigan JJ, Mitsias PD, Griffith B. Autoimmune encephalitis: pathophysiology and imaging review of an overlooked diagnosis. AJNR Am J Neuroradiol. 2017;38:1070\u20138.","journal-title":"AJNR Am J Neuroradiol"},{"key":"1067_CR44","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1016\/S2215-0366(17)30330-9","volume":"4","author":"M Peer","year":"2017","unstructured":"Peer M, Pr\u00fcss H, Ben-Dayan I, Paul F, Arzy S, Finke C. Functional connectivity of large-scale brain networks in patients with anti-NMDA receptor encephalitis: an observational study. Lancet Psychiatry. 2017;4:768\u201374.","journal-title":"Lancet Psychiatry"},{"key":"1067_CR45","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1191\/096120300678828695","volume":"9","author":"G Sanna","year":"2000","unstructured":"Sanna G, Piga M, Terryberry JW, et al. Central nervous system involvement in systemic lupus erythematosus: cerebral imaging and serological profile in patients with and without overt neuropsychiatric manifestations. Lupus. 2000;9:573\u201383.","journal-title":"Lupus"},{"key":"1067_CR46","first-page":"55","volume":"30","author":"P Chiewthanakul","year":"2012","unstructured":"Chiewthanakul P, Sawanyawisuth K, Foocharoen C, Tiamkao S. Clinical features and predictive factors in neuropsychiatric lupus. Asian Pac J Allergy Immunol. 2012;30:55\u201360.","journal-title":"Asian Pac J Allergy Immunol"},{"key":"1067_CR47","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/S0887-8994(99)00116-2","volume":"22","author":"JT Nasr","year":"2000","unstructured":"Nasr JT, Andriola MR, Coyle PK. ADEM: literature review and case report of acute psychosis presentation. Pediatr Neurol. 2000;22:8\u201318.","journal-title":"Pediatr Neurol"},{"key":"1067_CR48","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.msard.2016.12.012","volume":"12","author":"CR Camara-Lemarroy","year":"2017","unstructured":"Camara-Lemarroy CR, Ibarra-Yruegas BE, Rodriguez-Gutierrez R, Berrios-Morales I, Ionete C, Riskind P. The varieties of psychosis in multiple sclerosis: a systematic review of cases. Mult Scler Relat Disord. 2017;12:9\u201314.","journal-title":"Mult Scler Relat Disord"},{"key":"1067_CR49","doi-asserted-by":"crossref","unstructured":"Arneth BM. Multiple sclerosis and schizophrenia. Int J Mol Sci. 2017;18","DOI":"10.3390\/ijms18081760"},{"key":"1067_CR50","first-page":"76","volume":"31","author":"S Kapoor","year":"2014","unstructured":"Kapoor S. Psychosis: a rare but serious psychiatric anomaly in patients with sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis. 2014;31:76\u20137.","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"1067_CR51","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/S1474-4422(09)70324-2","volume":"9","author":"E Lancaster","year":"2010","unstructured":"Lancaster E, Lai M, Peng X, et al. Antibodies to the GABA(B) receptor in limbic encephalitis with seizures: case series and characterisation of the antigen. Lancet Neurol. 2010;9:67\u201376.","journal-title":"Lancet Neurol"},{"key":"1067_CR52","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1212\/WNL.0b013e31820e7b8d","volume":"76","author":"A Boronat","year":"2011","unstructured":"Boronat A, Sabater L, Saiz A, Dalmau J, Graus F. GABA(B) receptor antibodies in limbic encephalitis and anti-GAD-associated neurologic disorders. Neurology. 2011;76:795\u2013800.","journal-title":"Neurology"},{"key":"1067_CR53","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1007\/s00401-001-0498-0","volume":"103","author":"F Bernal","year":"2002","unstructured":"Bernal F, Graus F, Pifarr\u00e9 A, Saiz A, Benyahia B, Ribalta T. Immunohistochemical analysis of anti-Hu-associated paraneoplastic encephalomyelitis. Acta Neuropathol. 2002;103:509\u201315.","journal-title":"Acta Neuropathol"},{"key":"1067_CR54","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1097\/WNN.0b013e31828b6531","volume":"26","author":"S Najjar","year":"2013","unstructured":"Najjar S, Pearlman D, Devinsky O, et al. Neuropsychiatric autoimmune encephalitis without VGKC-complex, NMDAR, and GAD autoantibodies: case report and literature review. Cogn Behav Neurol. 2013;26:36\u201349.","journal-title":"Cogn Behav Neurol"},{"key":"1067_CR55","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.genhosppsych.2013.05.005","volume":"35","author":"K Shah","year":"2013","unstructured":"Shah K, Iloh N, Tabares P, Nnadi C, Sharif Z, Macaluso C. Limbic encephalitis and psychosis. Gen Hosp Psychiatry. 2013;35:682. e1-2","journal-title":"Gen Hosp Psychiatry"},{"key":"1067_CR56","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1097\/WNN.0b013e3182248193","volume":"24","author":"S Najjar","year":"2011","unstructured":"Najjar S, Pearlman D, Zagzag D, Devinsky O. Spontaneously resolving seronegative autoimmune limbic encephalitis. Cogn Behav Neurol. 2011;24:99\u2013105.","journal-title":"Cogn Behav Neurol"},{"key":"1067_CR57","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1136\/practneurol-2011-000084","volume":"11","author":"SA Ahmad","year":"2011","unstructured":"Ahmad SA, Archer HA, Rice CM, Gerhand S, Bradley M, Wilkins A. Seronegative limbic encephalitis: case report, literature review and proposed treatment algorithm. Pract Neurol. 2011;11:355\u201361.","journal-title":"Pract Neurol"},{"key":"1067_CR58","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1136\/jnnp.2006.093096","volume":"78","author":"SR Samarasekera","year":"2007","unstructured":"Samarasekera SR, Vincent A, Welch JL, et al. Course and outcome of acute limbic encephalitis with negative voltage-gated potassium channel antibodies. J Neurol Neurosurg Psychiatry. 2007;78:391\u20134.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1067_CR59","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1097\/WNN.0b013e318190d195","volume":"22","author":"A Modoni","year":"2009","unstructured":"Modoni A, Masciullo M, Spinelli P, et al. Successful treatment of acute autoimmune limbic encephalitis with negative VGKC and NMDAR antibodies. Cogn Behav Neurol. 2009;22:63\u20136.","journal-title":"Cogn Behav Neurol"},{"key":"1067_CR60","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1097\/WNN.0000000000000134","volume":"30","author":"J Toro","year":"2017","unstructured":"Toro J, Cuellar-Giraldo D, Duque A, Minota K, Pati\u00f1o J, Garc\u00eda M. Seronegative paraneoplastic limbic encephalitis associated with thymoma. Cogn Behav Neurol. 2017;30:125\u20138.","journal-title":"Cogn Behav Neurol"},{"key":"1067_CR61","doi-asserted-by":"publisher","unstructured":"Hirakawa H, Terao T, Ninomiya T, Amano Y, Aso Y, Matsubara E. The Effects of Carbamazepine and Lithium Combination on Serious Aggression and Anger Outbursts in a Case of Seronegative Limbic Encephalitis. Prim Care Companion CNS Disord. 2015;17. https:\/\/doi.org\/10.4088\/PCC.15l01802 .","DOI":"10.4088\/PCC.15l01802"},{"key":"1067_CR62","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/S1474-4422(13)70282-5","volume":"13","author":"N Gresa-Arribas","year":"2014","unstructured":"Gresa-Arribas N, Titulaer MJ, Torrents A, et al. Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study. Lancet Neurol. 2014;13:167\u201377.","journal-title":"Lancet Neurol"},{"key":"1067_CR63","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1002\/ana.24545","volume":"79","author":"E Castillo-Gomez","year":"2016","unstructured":"Castillo-Gomez E, K\u00e4stner A, Steiner J, et al. The brain as immunoprecipitator of serum autoantibodies against N-methyl-D-aspartate receptor subunit NR1. Ann Neurol. 2016;79:144\u201351.","journal-title":"Ann Neurol"},{"key":"1067_CR64","doi-asserted-by":"crossref","unstructured":"McCracken L, Junxian Zhang J, Greene M, et al. Improving the antibody-based evaluation of autoimmune encephalitis. Neurol Neuroimmunol Neuroinflamm. 2017;4:e404.","DOI":"10.1212\/NXI.0000000000000404"},{"key":"1067_CR65","doi-asserted-by":"publisher","first-page":"e352","DOI":"10.1212\/NXI.0000000000000352","volume":"4","author":"JC Probasco","year":"2017","unstructured":"Probasco JC, Solnes L, Nalluri A, et al. Abnormal brain metabolism on FDG-PET\/CT is a common early finding in autoimmune encephalitis. Neurol Neuroimmunol Neuroinflamm. 2017;4:e352.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"1067_CR66","first-page":"236","volume":"68","author":"AP Rozin","year":"2010","unstructured":"Rozin AP, Hasin T, Toledano K, Guralnik L, Balbir-Gurman A. Seronegative polyarthritis as severe systemic disease. Neth J Med. 2010;68:236\u201341.","journal-title":"Neth J Med"},{"key":"1067_CR67","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1002\/brb3.14","volume":"1","author":"K Ohta","year":"2011","unstructured":"Ohta K, Seki M, Dalmau J, Shinohara Y. Perfusion IMP-SPECT shows reversible abnormalities in GABA(B) receptor antibody associated encephalitis with normal MRI. Brain Behav. 2011;1:70\u20132.","journal-title":"Brain Behav"},{"key":"1067_CR68","doi-asserted-by":"publisher","first-page":"e23","DOI":"10.1016\/j.biopsych.2013.07.041","volume":"75","author":"S Najjar","year":"2014","unstructured":"Najjar S, Pearlman DM, Hirsch S, et al. Brain biopsy findings link major depressive disorder to neuroinflammation, oxidative stress, and neurovascular dysfunction: a case report. Biol Psychiatry. 2014;75:e23\u20136.","journal-title":"Biol Psychiatry"},{"key":"1067_CR69","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s13139-017-0475-8","volume":"51","author":"MM Alam","year":"2017","unstructured":"Alam MM, Lee J, Lee SY. Recent progress in the development of TSPO PET ligands for neuroinflammation imaging in neurological diseases. Nucl Med Mol Imaging. 2017;51:283\u201396.","journal-title":"Nucl Med Mol Imaging"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-018-1067-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,14]],"date-time":"2022-08-14T06:33:28Z","timestamp":1660458808000},"score":1,"resource":{"primary":{"URL":"https:\/\/jneuroinflammation.biomedcentral.com\/articles\/10.1186\/s12974-018-1067-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,13]]},"references-count":69,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["1067"],"URL":"https:\/\/doi.org\/10.1186\/s12974-018-1067-y","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,2,13]]},"assertion":[{"value":"7 November 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"40"}}